When does Charles River Laboratories International, Inc. (CRL) report earnings? On Nov 4, 2026, before the open
None of its last 12 announcements carries a time on the filing, so there is no way to say which session they fell in. Each one comes from the 8-K with item 2.02 that Charles River Laboratories International filed with the SEC, paired with the 10-Q or 10-K for that same quarter: 65 quarters since Aug 2, 2010, and every row links to its filing.
Next announced date: Nov 4, 2026, before the open. It comes from the company through the public Nasdaq calendar, not from the SEC: it is a scheduled date and companies do move it. Everything else on this page already happened, with its filing attached.
The last 20 quarters, one by one
"Lead": trading sessions between the announcement and the full quarterly report to the SEC (10-Q, or 10-K at fiscal year end). For Charles River Laboratories International, a median of 0 sessions over the last 12 quarters, i.e. the same market day.
| Announcement | Day | Time (NY) | Session | Quarter ended | SEC report | Lead | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Wednesday | no time on the filing | Jun 27, 2026 | 10-Q · Aug 5, 2026 | 0 sessions | 8-K | |
| May 7, 2026 | Thursday | no time on the filing | Mar 28, 2026 | 10-Q · May 7, 2026 | 0 sessions | 8-K | |
| Feb 18, 2026 | Wednesday | no time on the filing | Dec 27, 2025 | 10-K · Feb 18, 2026 | 0 sessions | 8-K | |
| Nov 5, 2025 | Wednesday | no time on the filing | Sep 27, 2025 | 10-Q · Nov 5, 2025 | 0 sessions | 8-K | |
| Aug 6, 2025 | Wednesday | no time on the filing | Jun 28, 2025 | 10-Q · Aug 6, 2025 | 0 sessions | 8-K | |
| May 7, 2025 | Wednesday | no time on the filing | Mar 29, 2025 | 10-Q · May 7, 2025 | 0 sessions | 8-K | |
| Feb 19, 2025 | Wednesday | no time on the filing | Dec 28, 2024 | 10-K · Feb 19, 2025 | 0 sessions | 8-K | |
| Nov 6, 2024 | Wednesday | no time on the filing | Sep 28, 2024 | 10-Q · Nov 6, 2024 | 0 sessions | 8-K | |
| Aug 7, 2024 | Wednesday | no time on the filing | Jun 29, 2024 | 10-Q · Aug 7, 2024 | 0 sessions | 8-K | |
| May 9, 2024 | Thursday | no time on the filing | Mar 30, 2024 | 10-Q · May 9, 2024 | 0 sessions | 8-K | |
| Feb 14, 2024 | Wednesday | no time on the filing | Dec 30, 2023 | 10-K · Feb 14, 2024 | 0 sessions | 8-K | |
| Nov 8, 2023 | Wednesday | no time on the filing | Sep 30, 2023 | 10-Q · Nov 8, 2023 | 0 sessions | 8-K | |
| Aug 9, 2023 | Wednesday | no time on the filing | Jul 1, 2023 | 10-Q · Aug 9, 2023 | 0 sessions | 8-K | |
| May 11, 2023 | Thursday | no time on the filing | Apr 1, 2023 | 10-Q · May 11, 2023 | 0 sessions | 8-K | |
| Feb 22, 2023 | Wednesday | no time on the filing | Dec 31, 2022 | 10-K · Feb 22, 2023 | 0 sessions | 8-K | |
| Nov 2, 2022 | Wednesday | no time on the filing | Sep 24, 2022 | 10-Q · Nov 2, 2022 | 0 sessions | 8-K | |
| Aug 3, 2022 | Wednesday | no time on the filing | Jun 25, 2022 | 10-Q · Aug 3, 2022 | 0 sessions | 8-K | |
| May 4, 2022 | Wednesday | no time on the filing | Mar 26, 2022 | 10-Q · May 4, 2022 | 0 sessions | 8-K | |
| Feb 16, 2022 | Wednesday | no time on the filing | Dec 25, 2021 | 10-K · Feb 16, 2022 | 0 sessions | 8-K | |
| Nov 3, 2021 | Wednesday | no time on the filing | Sep 25, 2021 | 10-Q · Nov 3, 2021 | 0 sessions | 8-K |
The table shows the 20 most recent quarters. All 65 are in the CSV, with the same columns and one row per quarter.
Download all 65 CRL quarters as CSV → Free, no account.
How Charles River Laboratories International shares moved on their latest earnings
Reported EPS beat the consensus estimate in 5 of the 5 quarters with an estimate.
| Announcement | Session | Window, close to close | CRL | SPY | EPS actual / expected |
|---|---|---|---|---|---|
| Aug 5, 2026 | no time on the filing | no time: unknown which close caught it | 3.02 / 2.74 (+10.3%) | ||
| May 7, 2026 | no time on the filing | no time: unknown which close caught it | 2.06 / 1.95 (+5.4%) | ||
| Feb 18, 2026 | no time on the filing | no time: unknown which close caught it | 2.39 / 2.35 (+1.9%) | ||
| Nov 5, 2025 | no time on the filing | no time: unknown which close caught it | 2.43 / 2.34 (+3.9%) | ||
| Aug 6, 2025 | no time on the filing | no time: unknown which close caught it | 3.12 / 2.55 (+22.4%) | ||
| May 7, 2025 | no time on the filing | no time: unknown which close caught it | |||
| Feb 19, 2025 | no time on the filing | no time: unknown which close caught it | |||
| Nov 6, 2024 | no time on the filing | no time: unknown which close caught it |
Split-adjusted closes and EPS with its estimate, from Yahoo Finance. It already happened: it does not anticipate the next announcement.
Where each number comes from
From the 8-K with item 2.02 ("Results of Operations and Financial Condition") that Charles River Laboratories International filed on EDGAR, the SEC's public database; only those with their 10-Q or 10-K behind them count, so other 8-Ks with the same item (production figures, monthly sales) stay out. No time is published for this company: its EDGAR acceptance stamp and the official header of its filings disagree, so there is no way to know whether the stamp is in New York time or UTC, and the two readings are four or five hours apart —enough to change session—. The dates are firm; the time and the session are deliberately left empty rather than filled in with a guess.
What this data does not know
- The exact time of the press release: the 8-K reaches EDGAR minutes or hours later, so any 8-K time is an upper bound. The session says which one the news landed in, not what minute it was said.
- Nothing before Aug 2, 2010: it is Charles River Laboratories International's oldest quarter with announcement and report paired in the file.
- What will happen. The page's only future date, Nov 4, 2026, was announced by Charles River Laboratories International on the Nasdaq calendar and can be moved.
- Charles River Laboratories International's identity is its SEC CIK (0001100682), not its symbol: symbols get recycled and renamed.
When other Healthcare companies report earnings
- MRNA
- LLY
- INCY
- CAH
- ELV
- SOLV
- BMY
- DXCM
- CVS
- HSIC
- VTRS
- JNJ
- DVA
- UHS
- CI
- BIIB
- VRTX
- REGN
- CNC
- MRK
- EW
- HUM
- MCK
- COR
- AMGN
- WAT
- WST
- TECH
- ABBV
- IDXX
- DGX
- RVTY
- MTD
- A
- ZBH
- ISRG
- TMO
- ALGN
- HCA
- UNH
- COO
- BDX
- VEEV
- MDT
- DHR
- PFE
- LH
- RMD
- IQV
- GEHC
- STE
- PODD
- BSX
- SYK
- BAX
- ZTS
- ABT
- GILD
- CCI
- SO
More on Charles River Laboratories International
Charles River Laboratories International is in the Healthcare sector. On the model's multifactor score of Oct 21, 2026 it ranks 429 of 464, and 52 of the 55 companies in its sector that score. It is a quantitative model ranking, not a recommendation.
Charles River Laboratories International (CRL) analysis page →
All ~500 S&P 500 companies, sorted by when they report →
Guide: 10-K, 10-Q and 8-K · all guides
What is behind these dates
The concepts on this page, explained from scratch in the Academy. Free, no account.
- Guessing next quarter's earnings gives no edgeWhy knowing a quarter's earnings in advance is not enough to make money: what moves the price is the gap against what was expected.
- Supply, demand and price: why it rises and falls constantlyWhat happens to the price on announcement day, and why excellent results can leave the stock falling.
- The three financial statements of a companyWhat is inside the 10-Q and the 10-K whose lag behind the announcement this page measures.
- Point-in-time data and look-ahead biasWhy the date a figure became public matters as much as the figure, which is exactly the distinction behind the two date columns above.
Source: EDGAR, the SEC's public database (forms 8-K, 10-Q and 10-K). Data through Aug 5, 2026. This is a list of public facts and of calculations made on them, not financial advice or a recommendation to buy or sell.